Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gut microbiome dysbiosis in patients with hepatitis B virus-related hepatocellular carcinoma after extended hepatectomy liver failure

1 May 2022

Abstract excerpt

Background: Hepatitis B virus-related hepatocellular carcinoma (B-HCC) negatively affects the gut microbiome. This study aimed to investigate the gut microbiome profiles and functions post-hepatectomy liver failure (PHLF) after extended hepatectomy (e-PHLF) to obtain valuable insights, identify potential diagnostic biomarkers, and assist in the treatment of this disease. Methods: B-HCC patients who underwent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gut microbiota and health
Share to Liver Disease Diagnosis and Treatment
Share to Metabolomics and Mass Spectrometry Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35722392
DOI: 10.21037/atm-22-1958

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gut microbiome dysbiosis in patients with hepatitis B virus-related hepatocellular carcinoma after extended hepatectomy liver failurePMID 35722392Read ↗

Immune modulation of gut microbiota and its metabolites in chronic hepatitis BSemantic proximity Read ↗

Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancerSemantic proximity Read ↗

Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B PatientsSemantic proximity Read ↗

The Microbiome and Hepatocellular CarcinomaSemantic proximity Read ↗

Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and TherapySemantic proximity Read ↗

Characterization of disease-associated microbiota in hepatocellular carcinomaSemantic proximity Read ↗

Interplay Between the Human Microbiome and Biliary Tract Cancer: Implications for Pathogenesis and TherapySemantic proximity Read ↗

Interplay between the Human Microbiome and Biliary Tract Cancer: Implications for Pathogenesis and TherapySemantic proximity Read ↗

Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changesSemantic proximity Read ↗

Distinct gut microbiota and metabolomic profiles in HBV-related liver cirrhosis: insights into disease progressionSemantic proximity Read ↗

A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinomaSemantic proximity Read ↗

Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.